Effect of Serum IgG1 to Cryptococcus neoformans Glucuronoxylomannan on Murine Pulmonary Infection

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 790-799

  Feldmesser, Marta ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIBODY; GLUCURONOXYLOMANNAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POLYSACCHARIDE;

A J MOUSE; ANIMAL; ARTICLE; CRYPTOCOCCOSIS; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LUNG DISEASE; MORTALITY; MOUSE; PATHOLOGY;

ANIMALS; ANTIBODIES, FUNGAL; CRYPTOCOCCOSIS; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; LUNG DISEASES; MICE; MICE, INBRED A; POLYSACCHARIDES;

EID: 0031568071     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Currie, B. P., and A. Casadevall. 1994. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin. Infect. Dis. 19:1029.
2. Levitz, S. M. 1991. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev. Infect. Dis. 13:1163.
3. + T cells. J. Exp. Med. 173:793.
4. Lipscomb, M. F., T. Alvarellos, G. B. Toews, R. Tompkins, Z. Evans, G. Koo, and V. Kumar. 1987. Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice. Am. J. Med. 128:354.
5. Levitz, S. M. 1994. Macrophage-Cryptococcus interactions. In Macrophage-Pathogen Interactions. B. S. Zwilling and T. K. Eisenstein, eds. Marcel Dekker, New York, p. 533.
6. Hill, J. O., and P. L. Dunn. 1993. A T cell-independent protective host response against Cryptococcus neoformans expressed at the primary site of infection in the lung. Infect. Immun. 61:5302.
7. Lipscomb, M. F. 1989. Lung defenses against opportunistic infections. Chest 96:1393.
8. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukocyte Biol. 55:35.
9. +) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J. Immunol. 144:1472.
10. + T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med. 175:1685.
11. Casadevall, A., J. Mukherjee, S. J. N. Devi, R. Schneerson, J. B. Robbins, and M. D. Scharff. 1992. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J. Infect. Dis. 165:1086.
12. Devi, S. J. N., R. Schneerson, W. Egan, T. J. Ulrich, D. Bryla, J. B. Robbins, and J. E. Bennett. 1991. Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect. Immun. 59:3700.
13. Zhong, Z., and L. Pirofski. 1996. Opsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomanna antibodies. Infect. Immun. 64:3446.
14. Casadevall, A., M. DeShaw, M. Fan, F. Dromer, T. R. Kozel, and L. Pirofski. 1994. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan. Infect. Immun. 62:3864.
15. Rinaldi, M. G., D. J. Drutz, A. Howell, M. A. Sande, C. B. Wofsy, and W. K. Hadley. 1986. Serotypes of Cryptococcus neoformans in patients with AIDS. J. Infect. Dis. 153:642.
16. Mukherjee, S., S. Lee, J. Mukherjee, M. D. Scharff, and A. Casadevall. 1994. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect. Immun. 62:1079.
17. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534.
18. Mukherjee, J., L. Pirofski, M. D. Scharff, and A. Casadevall. 1993. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc. Natl. Acad. Sci. USA 90:3636.
19. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1995. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infect. Immun. 63:3353.
20. Curtis, J. L., G. B. Huffnagle, G. Chen, M. L. Warnock, M. R. Gyetko, R. A. McDonald, and G. B. Toews. 1994. Experimental murine pulmonary cryptococcosis: differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab. Invest. 71:113.
21. Cherniak, R., L. C. Morris, B. C. Anderson, and S. A. Meyer. 1991. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect. Immun. 59:59.
22. L usage in polysaccharide binding antibodies. J. Exp. Med. 174:151.
23. Casadevall, A., J. Mukherjee, and M. D. Scharff. 1992. Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J. Immunol. Methods 154:27.
24. Cleare, W., S. Mukherjee, E. D. Spitzer, and A. Casadevall. 1994. Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies. Clin. Diagn. Lab. Immunol. 1:737.
25. Kozel, T. R., and G. S. T. Pfrommer. 1986. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast. Infect. Immun. 52:1.
26. Pottratz, S. T., and W. J. Martin II. 1990. Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages. J. Clin. Invest. 86:1678.
27. Ralph, P., J. Prichard, and M. Cohn. 1975. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity. J. Immunol. 114:898.
28. Mukherjee, S., S. C. Lee, and A. Casadevall. 1995. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect. Immun. 63:573.
29. Mukherjee, J., L. S. Zuckier, M. D. Scharff, and A. Casadevall. 1994. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob. Agents Chemother. 38:580.
30. Levitz, S. M., D. J. DiBenedetto, and R. D. Diamond. 1987. A rapid fluorescent assay to distinguish attached from phagocytized yeast particles. J. Immunol. Methods 101:37.
31. Pollock, R. R., D. L. French, J. P. Metlay, B. K. Birshtein, and M. D. Scharff. 1990. Intravascular metabolism of normal and mutant mouse immunoglobulin molecules. Eur. J. Immunol. 20:2021.
32. Bulawa, C. E., D. W. Miller, L. K. Henry, and J. M. Becker. 1995. Attenuated virulence of chitin-dencient mutants of Candida albicans. Proc. Natl. Acad. Sci. USA 92:10570.
33. Mody, C. H., G. Chen, C. Jackson, J. L. Curtis, and G. B. Toews. 1994. In vivo depletion of murine CD8 positive T cells impairs survival during infection with a highly virulent strain of Cryptococcus neoformans. Mycopathologia 125:7.
34. Murphy, J. W., and G. C. Cozad. 1972. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect. Immun. 5:896.
35. Hirano, A., H. M. Zimmerman, and S. Levine. 1965. Fine structure of cerebral fluid accumulation. Arch. Neurol. 12:189.
36. Dong, Z. M., and J. W. Murphy. 1995. Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Infect. Immun. 63:2632.
37. Drouhet, E., and B. Dupont. 1979. Mycoses iatrogenes a localisation profonde dues a des champignons levuriformes opportunistes. Dermatologica 159:94.
38. Dong, Z. M., and J. W. Murphy. 1996. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J. Clin. Invest. 97:689.
39. Blackstock, R. 1996. Cryptococcal capsular polysaccharide utilizes an antigen-presenting cell to induce a T-suppressor cell to secrete TsF. J. Med. Vet. Mycol. 34:19.
40. Mozaffarian, N., J. W. Berman, and A. Casadevall. 1995. Immune complexes increase nitric oxide production by interferon-γ-stimulated murine macrophage-like J774.16 cells. J. Leukocyte Biol. 57:657.
41. Vasquez-Torres, A., J. Jones-Carson, and E. Balish. 1996. Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages. Infect. Immun. 64:3127.
42. Vecchiarelli, A., C. Retini, A. Casadevall, and F. Bistoni. 1996. Monoclonal antibody to Cryptococcus neoformans glucuronoxylomannan enhances antigen presenting capacity of human monocytes. In Third International Conference on Cryptococcus & Cryptococcosis. Paris, Abstract 2.4.
43. Mody, C. H., and R. M. Syme. 1996. Antigen processing and presentation of Cryptococcus neoformans. In Third International Conference on Cryptococcus & Cryptococcosis. Paris, Abstract IV.4.
44. Papadimitriou, J. M., T. A. Robertson, Y. Kletter, M. Aronson, and M. N-I. Walters. 1978. An ultrastructural examination of the interaction betwen macrophages and Cryptococcus neoformans. J. Pathol. 124:103.
45. Goldman, D., S. C. Lee, and A. Casadevall. 1994. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect. Immun. 62:4755.
46. Yasuoka, A., S. Kohno, H. Yamada, M. Kaku, and H. Koga. 1994. Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis. Microbiol. Immunol. 38:851.
47. Small, J. M., T. G. Mitchell, and R. W. Wheat. 1986. Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A. Infect. Immun. 54:735.
48. Mukherjee, S., M. Feldmesser, and A. Casadevall. 1996. J774 murine macrophage-fike cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J. Infect. Dis. 173:1222.
49. Levitz, S. M., and A. Tabuni. 1991. Binding of Cryptococcus neoformans by human cultured macrophages; requirements for multiple complement receptors and actin. J. Clin. Invest. 87:528.
50. Collins, H. L., and G. J. Bancroft. 1992. Cytokine enhancement of complement-dependent phagocytosis by macrophages; synergy of tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22:1447.
51. Schelenz, S., R. Malhotra, R. B. Sim, U. Holmskov, and G. J. Bancroft. 1995. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect. Immun. 63:3360.
52. Ooi, Y. M., and H. R. Colten. 1979. Genetic defect in secretion of complement C5 in mice. Nature 282:207.
53. Rhodes, J. C., L. S. Wicker, and W. J. Urba. 1980. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect. Immun. 29:494.
54. Kozel, T. R., G. S. T. Pfrommer, and D. Redelman. 1987. Activated neutrophils exhibit enhanced phagocytosis of Cryptococcus neoformans opsonized with normal human serum. Clin. Exp. Immunol. 70:238.
55. Lovchik, J. A., and M. F. Lipscomb. 1993. Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol. 9:617.